Cardiovascular Disease in HIV Patients: A Comprehensive Overview

For decades, human immunodeficiency virus (HIV) was primarily understood as a threat to the immune system. However, with advancements in antiretroviral therapy (ART) extending the lifespan of individuals living with HIV, cardiovascular disease (CVD) has emerged as a significant and growing health concern within this population. This article provides a comprehensive overview of the relationship between HIV and CVD, exploring the underlying mechanisms, clinical manifestations, diagnostic approaches, and treatment strategies.

The Rising Prevalence of CVD in People Living with HIV

The prevalence of cardiac involvement in individuals with AIDS has been reported to range between 28% and 73% ¹. Historically, CVD was less common in people with HIV due to the shorter life expectancy before the advent of effective ART. However, as individuals with HIV now live longer, more manifestations of cardiovascular disease are becoming apparent ¹. People living with HIV still face an increased incidence of cardiovascular pathology ².

Understanding the Pathogenesis of HIV-Associated CVD

The development of CVD in people living with HIV is multifactorial, involving both direct and indirect effects of the virus and its treatment. Advances in cardiac imaging and immunology have deepened our understanding of the underlying mechanisms ². Key factors contributing to this increased risk include:

• Chronic Inflammation: HIV infection is characterized by chronic immune activation and inflammation, even in individuals on ART. This chronic inflammation contributes to endothelial dysfunction and atherosclerosis.
• Viral Proteins: HIV proteins, such as gp120, can directly damage the cardiovascular system, leading to myocardial dysfunction and inflammation.
• ART-Related Metabolic Abnormalities: Some ART regimens can cause metabolic disturbances, including dyslipidemia (abnormal cholesterol levels), insulin resistance, and lipodystrophy (changes in body fat distribution), all of which increase CVD risk.
• Traditional Risk Factors: People living with HIV often have a higher prevalence of traditional CVD risk factors, such as hypertension, smoking, and family history of heart disease.

Clinical Manifestations of HIV-Associated CVD

HIV-associated CVD can manifest in various forms, including:

• Coronary Artery Disease: The most common form of CVD, characterized by narrowing of the coronary arteries, leading to angina (chest pain) and myocardial infarction (heart attack).
• Heart Failure: A condition in which the heart is unable to pump enough blood to meet the body’s needs.
• Cardiomyopathy: Disease of the heart muscle, which can lead to heart failure. Recent research highlights the significant link between HIV and cardiomyopathy, focusing on molecular mechanisms and clinical presentations ⁴.
• Arrhythmias: Irregular heartbeats.
• Pulmonary Hypertension: High blood pressure in the arteries of the lungs.

Diagnosis and Management

Early diagnosis and management of CVD in people living with HIV are crucial. Diagnostic approaches include:

• Electrocardiogram (ECG): To assess heart rhythm.
• Echocardiogram: To evaluate heart structure and function.
• Cardiac Magnetic Resonance Imaging (MRI): Provides detailed images of the heart.
• Coronary Angiography: To visualize the coronary arteries.
• Biomarker Testing: To assess levels of cardiac enzymes and inflammatory markers.

Management strategies focus on:

• Optimizing ART: Selecting ART regimens with a favorable metabolic profile.
• Managing Traditional Risk Factors: Controlling blood pressure, cholesterol, and blood sugar.
• Lifestyle Modifications: Encouraging a healthy diet, regular exercise, and smoking cessation.
• Pharmacological Therapy: Using medications to treat specific CVD conditions, such as heart failure or arrhythmias.

The Evolving Landscape of HIV and Cardiovascular Health

As the population of people living with HIV continues to age, the burden of CVD is expected to increase. Ongoing research is focused on understanding the complex interplay between HIV, ART, and cardiovascular health, with the goal of developing more effective prevention and treatment strategies. Cardiovascular involvement in patients with HIV has gained significant attention due to improved life expectancy and the long-term impact of the virus ³.

Disclaimer: This article provides general information and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.